Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Amgen Manufacturing Ltd
EIR
•Amgen Manufacturing Ltd•September 27, 2019

Amgen Manufacturing Ltd – FDA EIR, Sep 27, 2019

Record Details

Amgen Manufacturing Limited in Juncos, PR, underwent an FDA Pre-Approval inspection from September 23-27, 2019, under the Food, Drug, and Cosmetic Act. The inspection focused on the transfer of manufacturing operations for licensed biologics, Amjevita and MVASI. Two primary observations were identified: First, batch production records for both products lacked complete information regarding critical process parameters, such as blend speed and temperature, during drug substance blending. This was contrary to 21 CFR 211.188, which requires comprehensive batch documentation. Management indicated these parameters were not consistently documented because equipment was qualified and preset, but FDA emphasized the necessity for ongoing record-keeping. Second, the Process Performance Qualification (PPQ) for MVASI vial filling lacked complete documented evidence for key operational parameters obtained via data processing tools, violating 21 CFR 211.110(a). Although data was processed, the confirmatory output was not retained, hindering validation verification. Verbal deficiencies included inadequate facility maintenance and insufficient documentation for pre-construction activities. Amgen also provided inaccurate information, initially limiting access to manufacturing areas and the use of cameras. Management committed to submitting a written response to the Office of Pharmaceutical Quality Operations (OPQO) within 15 days.

Company
Amgen Manufacturing Ltd
Inspection date
September 27, 2019
Product type
Biologics
Office
Atlanta District Office
People
  • Alberto Nido (company_representative)
  • Noreen Muniz (Investigator)
  • Arleen Paulino (company_representative)
  • Rayne Waller (company_representative)
  • Pedro Acevedo (company_representative)
View Company Profile

ID · f5b745d0-e63f-4419-b722-b1d9cd31b179

Violation Codes6
21 CFR 211.110(a)21 CFR 820.19821 CFR 21121 CFR 211.18821 CFR 820.10021 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Amgen Manufacturing Ltd
  • 483 - 2023-07-05July 5, 2023
  • 483 - 2021-09-08September 8, 2021
  • 483 - 2020-02-27February 27, 2020
  • 483 - 2019-09-27September 27, 2019
  • 483 - 2019-05-08May 8, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amgen Manufacturing Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.